Sylvester-led research group unveils the first individual risk prediction model for multiple myeloma

Credit: Photo by Sylvester

The prediction model for individualized risk in newly diagnosed multiple myeloma, or IRMMa, improves on previous prognostic tools because it takes into account the biology of patients’ tumors, said Dr. C. Ola Landgren, chief of the Division of Myeloma and director of the Sylvester Myeloma Institute. This is important in many cancers, but especially in multiple myeloma, which is highly variable.

« Sylvester-led research group unveils the first individual risk prediction model for multiple myeloma

Credit: Photo by Sylvester

“This model can only grow with the help of the research community,” said Dr. Francesco Maura, an assistant professor at Sylvester and first author on the study. “The next challenge is to keep feeding it with the right datasets so at a certain point it will be usable for clinical purposes.”

« Sylvester-led research group unveils the first individual risk prediction model for multiple myeloma

Expert Pitch

Expert Query

Expert Directory